Sat, Nov 01, 25
Anti-CGRP Monoclonal Antibody Migraine Treatment: Super-Responders and Absolute Responders and When to Expect Results
Anti-CGRP monoclonal antibodies achieved 70% super-response and 23% complete migraine freedom in a one-year study. Most dramatic improvements occurred after 6 months of treatment. For patients with chronic or high-frequency...
Read MoreAll Non-Invasive Neuromodulation Devices for Migraine Treatment
Wondering if migraine devices actually work? This guide breaks down the latest evidence on non-invasive neuromodulation devices like Cefaly, Nerivio, and gammaCore. Learn which devices have solid research backing them,...
Read MoreSun, Sep 14, 25
Neuroimaging Differences Between Migraine Types: Aura vs. Without Aura
Discover the latest neuroimaging research revealing key brain differences between migraine with aura and migraine without aura.
Read More
